|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-1-25
|
|
pubmed:abstractText |
To evaluate prospectively the acute and late morbidities from a multiinstitutional three-dimensional radiotherapy dose-escalation study for inoperable non-small-cell lung cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
318-28
|
|
pubmed:meshHeading |
pubmed-meshheading:15667949-Adenocarcinoma,
pubmed-meshheading:15667949-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15667949-Carcinoma, Squamous Cell,
pubmed-meshheading:15667949-Chemotherapy, Adjuvant,
pubmed-meshheading:15667949-Esophagus,
pubmed-meshheading:15667949-Female,
pubmed-meshheading:15667949-Humans,
pubmed-meshheading:15667949-Lung Neoplasms,
pubmed-meshheading:15667949-Male,
pubmed-meshheading:15667949-Middle Aged,
pubmed-meshheading:15667949-Multivariate Analysis,
pubmed-meshheading:15667949-Prospective Studies,
pubmed-meshheading:15667949-Radiation Injuries,
pubmed-meshheading:15667949-Radiotherapy, Conformal,
pubmed-meshheading:15667949-Radiotherapy Dosage
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Washington University Siteman Cancer Center, St. Louis, MO 63110, USA. bradley@radonc.wustl.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
